All News #Library
Biotech
VTv Therapeutics at 38th Annual Roth Conference
16 Mar 2026 //
GLOBENEWSWIRE
VTv Therapeutics Reveals 2025 Financials, Corporate Update
10 Mar 2026 //
GLOBENEWSWIRE
vTv Therapeutics to Participate in Upcoming Investor Conferences
13 Feb 2026 //
GLOBENEWSWIRE
VTV Therapeutics, M42 Submit Cadisegliatin Phase 2 Protocol in US
18 Dec 2025 //
GLOBENEWSWIRE
Vtv Therapeutics Reveals Q3 2025 Financials & Corporate Update
06 Nov 2025 //
GLOBENEWSWIRE
vTv Therapeutic Starts Ph 3 Cadisegliatin Trial in Type1 Diabetes
07 Aug 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support